Idorsia Ltd (OTCMKTS:IDRSF – Get Free Report)’s stock price shot up 50% on Friday . The stock traded as high as $1.50 and last traded at $1.50. 1,200 shares were traded during mid-day trading, an increase of 46% from the average session volume of 823 shares. The stock had previously closed at $1.00.
Idorsia Stock Performance
The business’s 50-day moving average is $1.11 and its two-hundred day moving average is $1.01.
About Idorsia
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.
Recommended Stories
- Five stocks we like better than Idorsia
- The Significance of Brokerage Rankings in Stock Selection
- Google Is Betting Big on Nuclear Reactors—Should You?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- The Role Economic Reports Play in a Successful Investment Strategy
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.
